Kids' gut drug faces Long-Term safety check
Disease control
ENROLLING_BY_INVITATION
This study aims to check the long-term safety of the drug tenapanor in children and teenagers (ages 6-18) who have irritable bowel syndrome with constipation (IBS-C). It is open to patients who successfully completed a previous related study. Participants will continue taking the…
Phase: PHASE3 • Sponsor: Ardelyx • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC